Search research articles
Contact Us
Filters
Showing results (201-210 of 207) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 207 results.
Leukemia
|
January 27, 2006
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial
R F Schlenk, S Fröhling, F Hartmann, et al.
Blut
|
September 1, 1981
Lymphoplasmacytic/lymphoplasmacytoid lymphoma: a clinical entity distinct from chronic lymphocytic leukaemia?
R Heinz, A Stacher, H Pralle, et al.
Leukemia
|
September 24, 2004
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
R F Schlenk, S Fröhling, F Hartmann, et al.
Leukemia & Lymphoma
|
July 28, 2016
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction
M Engelhard, G Brittinger, R Heinz, et al.
Blood
|
February 24, 2007
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, et al.
Leukemia
|
July 30, 2003
Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea
R Hehlmann, U Berger, M Pfirrmann, et al.
ACS Nano
|
March 10, 2025
Interfacing with the Brain: How Nanotechnology Can Contribute
Abdullah A A Ahmed, Nuria Alegret, Bethany Almeida, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 207) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 207 results.
Leukemia
|
January 27, 2006
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial
R F Schlenk, S Fröhling, F Hartmann, et al.
Blut
|
September 1, 1981
Lymphoplasmacytic/lymphoplasmacytoid lymphoma: a clinical entity distinct from chronic lymphocytic leukaemia?
R Heinz, A Stacher, H Pralle, et al.
Leukemia
|
September 24, 2004
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
R F Schlenk, S Fröhling, F Hartmann, et al.
Leukemia & Lymphoma
|
July 28, 2016
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction
M Engelhard, G Brittinger, R Heinz, et al.
Blood
|
February 24, 2007
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, et al.
Leukemia
|
July 30, 2003
Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea
R Hehlmann, U Berger, M Pfirrmann, et al.
ACS Nano
|
March 10, 2025
Interfacing with the Brain: How Nanotechnology Can Contribute
Abdullah A A Ahmed, Nuria Alegret, Bethany Almeida, et al.
Page
of 21